IBDEI1ZH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1594,0)
 ;;=FAMILY TRAINING-GROUP^2^149
 ;;^UTILITY(U,$J,358.4,1595,0)
 ;;=RECREATION THERAPY DIAGNOSES^1^150
 ;;^UTILITY(U,$J,358.4,1596,0)
 ;;=Primary Diagnosis for RCAT Therapy^1^151
 ;;^UTILITY(U,$J,358.4,1597,0)
 ;;=1-1 THERAPEUTIC PROCEDURES^1^152
 ;;^UTILITY(U,$J,358.4,1598,0)
 ;;=EDUCATION/TRAINING^3^152
 ;;^UTILITY(U,$J,358.4,1599,0)
 ;;=TEAM CONFERENCE^6^152
 ;;^UTILITY(U,$J,358.4,1600,0)
 ;;=ASSESSMENT^2^152
 ;;^UTILITY(U,$J,358.4,1601,0)
 ;;=FAMILY TRAINING^4^152
 ;;^UTILITY(U,$J,358.4,1602,0)
 ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^152
 ;;^UTILITY(U,$J,358.4,1603,0)
 ;;=Primary Diagnosis for RCAT Therapy^1^153
 ;;^UTILITY(U,$J,358.4,1604,0)
 ;;=RECREATION THERAPY DIAGNOSES^1^154
 ;;^UTILITY(U,$J,358.4,1605,0)
 ;;=NEW PATIENT^2^155
 ;;^UTILITY(U,$J,358.4,1606,0)
 ;;=ESTABLISHED PATIENT^1^155
 ;;^UTILITY(U,$J,358.4,1607,0)
 ;;=CONSULTATIONS^3^155
 ;;^UTILITY(U,$J,358.4,1608,0)
 ;;=THERAPY MODALITIES/PROCEDURES^12^156
 ;;^UTILITY(U,$J,358.4,1609,0)
 ;;=INJECTIONS/DRUGS^5^156
 ;;^UTILITY(U,$J,358.4,1610,0)
 ;;=ORTHOTIC DEVICES^8^156
 ;;^UTILITY(U,$J,358.4,1611,0)
 ;;=KINESIOTHERAPY^6^156
 ;;^UTILITY(U,$J,358.4,1612,0)
 ;;=THERAPY EVALUATIONS^11^156
 ;;^UTILITY(U,$J,358.4,1613,0)
 ;;=WOUND CARE^13^156
 ;;^UTILITY(U,$J,358.4,1614,0)
 ;;=CARDIAC REHAB^1^156
 ;;^UTILITY(U,$J,358.4,1615,0)
 ;;=EDUCATION/TRAINING^2^156
 ;;^UTILITY(U,$J,358.4,1616,0)
 ;;=HOME THERAPY SERVICES^4^156
 ;;^UTILITY(U,$J,358.4,1617,0)
 ;;=NEUROMUSCULAR TESTING^7^156
 ;;^UTILITY(U,$J,358.4,1618,0)
 ;;=TEAM CONFERENCE^10^156
 ;;^UTILITY(U,$J,358.4,1619,0)
 ;;=HEALTH BEHAVIORS^3^156
 ;;^UTILITY(U,$J,358.4,1620,0)
 ;;=RECREATION THERAPY^9^156
 ;;^UTILITY(U,$J,358.4,1621,0)
 ;;=PRIMARY DIAGNOSES^1^157
 ;;^UTILITY(U,$J,358.4,1622,0)
 ;;=V CODES ^11^158
 ;;^UTILITY(U,$J,358.4,1623,0)
 ;;=AMPUTATION STATUS^1^158
 ;;^UTILITY(U,$J,358.4,1624,0)
 ;;=BRAIN DISORDERS^2^158
 ;;^UTILITY(U,$J,358.4,1625,0)
 ;;=CARDIOPULMONARY^3^158
 ;;^UTILITY(U,$J,358.4,1626,0)
 ;;=COMPLICATION DUE TO^4^158
 ;;^UTILITY(U,$J,358.4,1627,0)
 ;;=FRACTURES-LATE EFFECTS^5^158
 ;;^UTILITY(U,$J,358.4,1628,0)
 ;;=MENTAL DISORDERS^6^158
 ;;^UTILITY(U,$J,358.4,1629,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^7^158
 ;;^UTILITY(U,$J,358.4,1630,0)
 ;;=TERTIARY DX-TBI CODES^10^158
 ;;^UTILITY(U,$J,358.4,1631,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^158
 ;;^UTILITY(U,$J,358.4,1632,0)
 ;;=PHYSICAL^8^158
 ;;^UTILITY(U,$J,358.4,1633,0)
 ;;=IMMUNIZATIONS/INJECTIONS^4^159
 ;;^UTILITY(U,$J,358.4,1634,0)
 ;;=RESPIRATORY^8^159
 ;;^UTILITY(U,$J,358.4,1635,0)
 ;;=SLEEP STUDIES^9^159
 ;;^UTILITY(U,$J,358.4,1636,0)
 ;;=PULMONARY FUNCTION TESTS^7^159
 ;;^UTILITY(U,$J,358.4,1637,0)
 ;;=OTHER^5^159
 ;;^UTILITY(U,$J,358.4,1638,0)
 ;;=ABG^1^159
 ;;^UTILITY(U,$J,358.4,1639,0)
 ;;=OXYGEN CLINIC^6^159
 ;;^UTILITY(U,$J,358.4,1640,0)
 ;;=CPAP^2^159
 ;;^UTILITY(U,$J,358.4,1641,0)
 ;;=EDUCATION/TRAINING GRP/IND^3^159
 ;;^UTILITY(U,$J,358.4,1642,0)
 ;;=SUPPLIES^10^159
 ;;^UTILITY(U,$J,358.4,1643,0)
 ;;=ESTABLISHED PT-OUTPT^1^160
 ;;^UTILITY(U,$J,358.4,1644,0)
 ;;=INPATIENT CARE^2^160
 ;;^UTILITY(U,$J,358.4,1645,0)
 ;;=SIGNS & SYMPTOMS^24^161
 ;;^UTILITY(U,$J,358.4,1646,0)
 ;;=ENDOCRINE & METABOLIC^6^161
 ;;^UTILITY(U,$J,358.4,1647,0)
 ;;=HEMATOLOGIC & LYMPHATIC^10^161
 ;;^UTILITY(U,$J,358.4,1648,0)
 ;;=EYES, EARS & NOSE^7^161
 ;;^UTILITY(U,$J,358.4,1649,0)
 ;;=VASCULAR^29^161
 ;;^UTILITY(U,$J,358.4,1650,0)
 ;;=MUSCULOSKELETAL^14^161
 ;;^UTILITY(U,$J,358.4,1651,0)
 ;;=GENITOURINARY & RENAL^9^161
 ;;^UTILITY(U,$J,358.4,1652,0)
 ;;=CARDIAC^3^161
 ;;^UTILITY(U,$J,358.4,1653,0)
 ;;=INTERSTITIAL LUNG DISEASES^13^161
